Crossmark

Elevated eosinophil-to-lymphocyte ratio (ELR) as a predictor of relapse for IgG4-related disease: a retrospective study across a decade

Crossref DOI link: https://doi.org/10.1007/s10238-025-01741-9

Published Online: 2025-06-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Nianyi

Peng, Yu

Li, Rongli

Nie, Yuxue

Li, Jingna

Yang, Xinli

Zhang, Jialei

Wang, Yifei

Luo, Qinhuan

Zhou, Jiaxin

Fei, Yunyun

Li, Mengtao

Peng, Linyi

Zhang, Wen
Funding

Funding for this research was provided by:

CAMS Innovation Fund for Medical Sciences (CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005, CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005, CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005, CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005, CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005, CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005, CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005, CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005, CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005, CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005, CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005, CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005, CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005, CIFMS 2021-1-I2M-003, 2022-I2M-C&T-B-005)

National High Level Hospital Clinical Research Funding ((2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013, (2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013, (2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013, (2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013, (2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013, (2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013, (2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013, (2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013, (2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013, (2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013, (2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013, (2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013, (2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013, (2022-PUMCH-C-006,2022-PUMCH-A-041,2022-PUMCH-B-013)

Beijing Natural Science Foundation (7232113, 7232113, 7232113, 7232113, 7232113, 7232113, 7232113, 7232113, 7232113, 7232113, 7232113, 7232113, 7232113, 7232113)

National Natural Science Foundation of China (82271848, 823B2037, 82471829, 82271848, 823B2037, 82471829, 82271848, 823B2037, 82471829, 82271848, 823B2037, 82471829, 82271848, 823B2037, 82471829, 82271848, 823B2037, 82471829, 82271848, 823B2037, 82471829, 82271848, 823B2037, 82471829, 82271848, 823B2037, 82471829, 82271848, 823B2037, 82471829, 82271848, 823B2037, 82471829, 82271848, 823B2037, 82471829, 82271848, 823B2037, 82471829, 82271848, 823B2037, 82471829)

National Key Research and Development Program of China (2022YFC2703104, 2022YFC2703104, 2022YFC2703104, 2022YFC2703104, 2022YFC2703104, 2022YFC2703104, 2022YFC2703104, 2022YFC2703104, 2022YFC2703104, 2022YFC2703104, 2022YFC2703104, 2022YFC2703104, 2022YFC2703104, 2022YFC2703104)
License Information

Text and Data Mining valid from 2025-06-09

Version of Record valid from 2025-06-09
More Information

Article History

Received: 5 February 2025

Accepted: 20 May 2025

First Online: 9 June 2025

Declarations

:

: The authors declare no competing interests.

: Ethics committee approval was obtained with a waiver of informed consent by the Ethics Committee of Peking Union Medical College Hospital (Number: S-442).

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below